Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation And ATS Certification
Portfolio Pulse from Benzinga Newsdesk
Champions Oncology, Inc. (NASDAQ:CSBR) has announced that its European research operations site in Bresso, Italy, has received ISO-9001:2015 laboratory accreditation from the Bureau Veritas S.p.A. and ATS certification from the Lombardy Region. These certifications validate the quality of clinical testing services that Champions Oncology's European research team can provide and will enable specialty testing of clinical patient sample across all phases for their global biopharma partners in Europe.
November 02, 2023 | 12:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Champions Oncology's European research operations site has received ISO-9001:2015 and ATS certifications. This validates the quality of their clinical testing services and could potentially lead to an expansion of their customer base in Europe.
The ISO-9001:2015 and ATS certifications are significant achievements that validate the quality of Champions Oncology's clinical testing services. This could potentially lead to an expansion of their customer base in Europe, which would likely have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100